breast cancer Archive — Page 12 of 22
-
May 30, 2017
Mix-and-match trial is actually precision medicine
-
April 20, 2017
Study examines new breast cancer drug combination
A study led by Vanderbilt-Ingram Cancer Center (VICC) investigators suggests a drug combination which includes a PDK1 protein blocker may be more effective for breast cancer that has become resistant to cyclin-dependent kinase (CDK4/6) targeted therapy. -
March 30, 2017
Horn to lead lung cancer combination therapy trial
Leora Horn, M.D., M.Sc., associate professor of Medicine and clinical director of the Thoracic Oncology Program at Vanderbilt-Ingram Cancer Center (VICC), has been selected to lead a clinical research trial of combination therapy using two targeted drugs for the treatment of a specific form of lung cancer. -
March 30, 2017
Research support
DS Services of America Inc. recently presented a $100,000 gift to Vanderbilt-Ingram Cancer Center (VICC) to support breast cancer research. -
March 23, 2017
Breast cancer program lands new research grants
Several investigators in Vanderbilt-Ingram Cancer Center’s (VICC) Breast Cancer Program have received grant awards to support translational research that may improve disease outcomes for patients. -
January 16, 2017
Softening tumor tissue could aid cancer treatments
Tumors cause the intracellular material surrounding them to stiffen. Softening this protective layer could make existing cancer treatments more effective, according to new research. -
December 6, 2016
Crucial Role of Surgeons in Cancer Treatment and Therapy